HLS Therapeutics Inc T.HLS

Alternate Symbol(s): HLTRF

HLS Therapeutics Inc. is a pharmaceutical company. It is focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Insite, MyCare Psychiatry, PERSERIS, Trinomia and Vascepa. Its lead product is Clozaril, which is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. Trinomia product related to the treatment of cardiovascular disease.

TSX:HLS - Post by User

HLS Therapeutics Inc

<< Previous

Bullboard Posts

Post by screamer99on Feb 06, 2024 12:24pm

128 Views

Post# 35865513

BC Drug Plan

Discussion boards are dead everywhere I can see, but the reimbursement from BC is big news.

Last March, when it was announced that discussions were ongoing, this stock fell from $8 to where it is now.

I would think the Alberta reimbursement will follow at some point this year.

Earnings may be flat for the next couple of quarters, but can't help but think this thing will be a few dollars higher by next summer.

Time will tell.

<< Previous

Bullboard Posts

Hempalta acquires controlling interest in Hemp Carbon Standard